Makino Y - Search Results

1

Pharmacokinetic and pharmacodynamic study on amrubicin and amrubicinol in Japanese patients with lung cancer.

Makino Y, Yamamoto N, Sato H, Ando R, Goto Y, Tanai C, Asahina H, Nokihara H, Sekine I, Kunitoh H, Ohe Y, Sugiyama E, Yokote N, Tamura T, Yamamoto H. Makino Y, et al. Cancer Chemother Pharmacol. 2012 Apr;69(4):861-9. doi: 10.1007/s00280-011-1768-8. Epub 2011 Nov 1. Cancer Chemother Pharmacol. 2012. PMID: 22042514

2

Simple and sensitive HPLC method for determination of amrubicin and amrubicinol in human plasma: application to a clinical pharmacokinetic study.

Ando R, Makino Y, Tamura T, Yamamoto N, Nishigaki R, Kimura T, Yokote N, Yamamoto H. Ando R, et al. Among authors: makino y. Biomed Chromatogr. 2010 Mar;24(3):301-6. doi: 10.1002/bmc.1289. Biomed Chromatogr. 2010. PMID: 19634123

3

Gender difference in hematological toxicity among lung cancer patients receiving amrubicin monotherapy.

Makihara RA, Makino Y, Yamamoto N, Yokote N, Nokihara H, Sekine I, Ohe Y, Tamura T, Yamamoto H. Makihara RA, et al. Among authors: makino y. Jpn J Clin Oncol. 2012 Dec;42(12):1187-91. doi: 10.1093/jjco/hys170. Epub 2012 Oct 17. Jpn J Clin Oncol. 2012. PMID: 23081985

4

Phase I dose-finding and pharmacokinetic study of docetaxel and gefitinib in patients with advanced or metastatic non-small-cell lung cancer: evaluation of drug-drug interaction.

Motonaga M, Yamamoto N, Makino Y, Ando-Makihara R, Ohe Y, Takano M, Hayashi Y. Motonaga M, et al. Among authors: makino y. Cancer Chemother Pharmacol. 2015 Oct;76(4):713-21. doi: 10.1007/s00280-015-2837-1. Epub 2015 Aug 2. Cancer Chemother Pharmacol. 2015. PMID: 26233803 Clinical Trial.

5

Simultaneous optimization of limited sampling points for pharmacokinetic analysis of amrubicin and amrubicinol in cancer patients.

Makino Y, Watanabe M, Makihara RA, Nokihara H, Yamamoto N, Ohe Y, Sugiyama E, Sato H, Hayashi Y. Makino Y, et al. Asia Pac J Clin Oncol. 2016 Sep;12(3):259-64. doi: 10.1111/ajco.12485. Epub 2016 Mar 7. Asia Pac J Clin Oncol. 2016. PMID: 26948073

6

Individual optimal dose of amrubicin to prevent severe neutropenia in Japanese patients with lung cancer.

Makino Y, Makihara-Ando R, Ogawa T, Sato H, Goto Y, Kanda S, Horinouchi H, Fujiwara Y, Ohe Y, Yamamoto N. Makino Y, et al. Cancer Sci. 2019 Nov;110(11):3573-3583. doi: 10.1111/cas.14194. Epub 2019 Oct 3. Cancer Sci. 2019. PMID: 31505087 Free PMC article.

7

Evaluation of hepatic CYP3A enzyme activity using endogenous markers in lung cancer patients treated with cisplatin, dexamethasone, and aprepitant.

Hibino H, Sakiyama N, Makino Y, Makihara-Ando R, Horinouchi H, Fujiwara Y, Kanda S, Goto Y, Yoshida T, Okuma Y, Shinno Y, Murakami S, Hashimoto H, Akiyoshi T, Imaoka A, Ohe Y, Yamaguchi M, Ohtani H. Hibino H, et al. Among authors: makino y. Eur J Clin Pharmacol. 2022 Apr;78(4):613-621. doi: 10.1007/s00228-022-03275-5. Epub 2022 Jan 17. Eur J Clin Pharmacol. 2022. PMID: 35039908

8

Early change in the clearance of pembrolizumab reflects the survival and therapeutic response: A population pharmacokinetic analysis in real-world non-small cell lung cancer patients.

Ohuchi M, Yagishita S, Jo H, Akagi K, Inaba Higashiyama R, Masuda K, Shinno Y, Okuma Y, Yoshida T, Goto Y, Horinouchi H, Makino Y, Yamamoto N, Ohe Y, Hamada A. Ohuchi M, et al. Among authors: makino y. Lung Cancer. 2022 Nov;173:35-42. doi: 10.1016/j.lungcan.2022.08.018. Epub 2022 Sep 6. Lung Cancer. 2022. PMID: 36116168

9

Significant association between hand-foot syndrome and efficacy of capecitabine in patients with metastatic breast cancer.

Azuma Y, Hata K, Sai K, Udagawa R, Hirakawa A, Tohkin M, Ryushima Y, Makino Y, Yokote N, Morikawa N, Fujiwara Y, Saito Y, Yamamoto H. Azuma Y, et al. Among authors: makino y. Biol Pharm Bull. 2012;35(5):717-24. doi: 10.1248/bpb.35.717. Biol Pharm Bull. 2012. PMID: 22687407 Free article.

10

Feasibility of dose-dense paclitaxel/carboplatin therapy in elderly patients with ovarian, fallopian tube, or peritoneal cancer.

Bun S, Yunokawa M, Ebata T, Shimomura A, Shimoi T, Kodaira M, Yonemori K, Shimizu C, Fujiwara Y, Kato T, Makino Y, Hayashi Y, Tamura K. Bun S, et al. Among authors: makino y. Cancer Chemother Pharmacol. 2016 Oct;78(4):745-52. doi: 10.1007/s00280-016-3100-0. Epub 2016 Aug 13. Cancer Chemother Pharmacol. 2016. PMID: 27522647

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,103 results

Search Page

Filters